SENDERO BIOTECHNOLOGY, INC.
Rochester, US · Founded 2021 · Delaware corporation · 1 known investors
Founders & leadership
MC
Michael ColaNamed on SEC filing
AB
Andrew BadleyNamed on SEC filing
JB
Joshua BarerNamed on SEC filing
GO
Gloria OlivierNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.3M disclosed across 1 round · 2023
▶$7.3MraisedApr 2023 · 2 investors · BiotechnologyRule 506(b)
▶$7.3MraisedApr 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ColaExecutive Officer, Director
- Andrew BadleyDirector
- Joshua BarerDirector
- Gloria OlivierDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are SENDERO BIOTECHNOLOGY, INC.'s investors?
- SENDERO BIOTECHNOLOGY, INC.'s investors include Hibiscus Capital Management.
- How much funding has SENDERO BIOTECHNOLOGY, INC. raised?
- SENDERO BIOTECHNOLOGY, INC. has disclosed $7.3M raised across 1 round.
- Where is SENDERO BIOTECHNOLOGY, INC. headquartered?
- SENDERO BIOTECHNOLOGY, INC. is headquartered in Rochester, US.